ADDITIVE NEUROPROTECTIVE EFFECT OF 3-HYDROXYPYRIDINE DERIVATIVES AND HUMAN ERYTHROPOETIN ANALOGUE ON A HEMORRHAGIC STROKE MODEL IN RATS

QR Code

ADDITIVE NEUROPROTECTIVE EFFECT OF 3-HYDROXYPYRIDINE DERIVATIVES AND HUMAN ERYTHROPOETIN ANALOGUE ON A HEMORRHAGIC STROKE MODEL IN RATS

The correction of free radical oxidation processes is one of the most promising strategies of neuroprotection in acute cerebrovascular disorders.The aim of the study is an experimental study of the neuroprotective effects of 3-hydroxypyridine and erythropoietin derivatives, as well as their combined...

Full description

Saved in:

Bibliographic Details
Main Authors:	P. D. Kolesnichenko, O. V. Scheblykina, N. I. Nesterova, D. V. Scheblykin, A. V. Nesterov, M. V. Pokrovskiy, M. A. Zhuchenko, A. V. Tverskoy, K. M. Reznikov
Format:	Article
Language:	Russian
Published:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2020-12-01
Series:	Фармация и фармакология (Пятигорск)
Subjects:	hemorrhagic stroke 3-hydroxypyridines carbamylated darbepoetin neuroprotection
Online Access:	https://www.pharmpharm.ru/jour/article/view/711
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

THE STUDY OF RENOPROTECTIVE PROPERTIES OF ERYTROPOETIN DERIVATIVES ON THE KIDNEY ISCHEMIA-REPERFUSION MODEL
by: V. V. Elagin, et al.
Published: (2018-12-01)

Antimicrobial evaluation, molecular docking, DFT analysis, and ADME studies of 3-Hydroxypyridin-4-one analogues
by: Hossein Sadeghpour, et al.
Published: (2025-07-01)

The effect of a new 3-hydroxypyridine derivative LHT-2-20 on free radical oxidation in experimental periodontitis
by: G. V. Poryadin, et al.
Published: (2024-10-01)

METHOD OF FLUORIMETRIC DETERMINATION OF POTASSIUM CYANATE IN CARBAMYLATED DARBEPOIETIN ALPHA DRUG SUBSTANCE
by: A. D. Askretkov, et al.
Published: (2019-01-01)

The role of urea in pathological conditions
by: O.B. Kvasnytska, et al.
Published: (2025-06-01)

DETERMINATION OF DARBEPOETIN ALFA IN RABBIT PLASMA BY ELISA
by: M. V. Karlina, et al.
Published: (2019-01-01)

Approaches to treating anemia in patients with malignancies. The 2007—2008 changes in Russian and International practice
by: N. V. Zhukov
Published: (2022-11-01)

2024 international conference on neuroprotective agents conference proceedings
by: William Slikker, et al.
Published: (2025-07-01)

RESEARCH OF NEUROPROTECTIVE ACTIVITY OF PHYTOREMEDY «PHYTOTON»
by: T. B. Smagulova, et al.
Published: (2012-11-01)

The use of darbepoetin alpha in infants
by: A. V. Shchegolev, et al.
Published: (2019-06-01)

Study of the neuroprotective properties of metformin in rats with type 2 diabetes mellitus and brain injury induced by intracerebral hemorrhage
by: V.L. Holubiev, et al.
Published: (2024-06-01)

Exploration of neuroprotective strategies in patients with acute promyelocytic leukemia complicated by cerebral hemorrhage
by: Jing Hu, et al.
Published: (2025-07-01)

THE SEARCH FOR NEUROPROTECTIVE COMPOUNDS AMONG NEW ETHYLTHIADIAZOLE DERIVATIVES
by: R. F. Cherevatenko, et al.
Published: (2021-01-01)

Quantification of polysorbate 80 in biopharmaceutical formulations implementing an optimized colorimetric approach
by: A. S. Seregin, et al.
Published: (2020-07-01)

DRUG NEUROPROTECTION IN FULL-TERM NEWBORNS WITH SEVERE CEREBRAL ISCHEMIA
by: A. A. Zadvornov, et al.
Published: (2018-01-01)

Neuroprotective and anticonvulsant effects of Cerebrolysin in the experiment
by: T. E. Bogacheva, et al.
Published: (2017-11-01)

Protective role of 3-oxypyridine derivatives in rats’ steroid-induced osteoporosis associated with reduced oxidative stress and recovery of nitric oxide formation
by: A. P. Danilenko, et al.
Published: (2023-05-01)

Hypotensive glaucoma therapy and neuroprotection
by: A. N. Zhuravleva, et al.
Published: (2020-05-01)

NEUROPROTECTIVE AND MNEMOTROPIC EFFECTS OF SOMNIFACIENTS AT DIFFUSE AXONAL INJURY
by: Y. S. Safronova, et al.
Published: (2014-07-01)

Fractal Phototherapy in Neuroprotection of Glaucoma
by: M. V. Zueva, et al.
Published: (2019-10-01)

Anti-hypertensive therapy as a basis for neuroprotection in modern clinical practice
by: V. N. Shishkova
Published: (2021-06-01)

Evaluation of the neuroprotective activity of a new allylmorpholine derivative in a rat model of traumatic brain injury
by: V. A. Prikhodko, et al.
Published: (2021-12-01)

NOOTROPICS AND MELAXEN’ NEUROPROTECTIONAL ACTIVITY MORPHOPHARMACOLOGICAL ANALYSIS IN RATS’ ACUTE CEREBRAL ISCHEMIA
by: E. V. Gantsgorn, et al.
Published: (2015-09-01)

Neuroprotective Properties of Xenon According to Experimental Studies
by: O. A. Grebenchikov, et al.
Published: (2020-10-01)

Study of neuroprotective and insulinotropic activities of hydroponic Teucrium polium L in condition ovariectomy
by: Chavushyan V. A., et al.
Published: (2012-01-01)

Correction of mitochondrial dysfunction with trimethoxy-substituted monocarbonyl curcumin analogues in experimental Alzheimer’s disease
by: D. I. Pozdnyakov, et al.
Published: (2024-01-01)

Perioperative Neuroprotection with Systemic Hypothermia During Carotid Endarterectomy
by: Alexey A. Syrovatsky, et al.
Published: (2025-02-01)

The effect of new derivatives of 3-hydroxypyridine on the development of brain edema in bacterial purulent meningitis in experimental conditions
by: A. A. Agarkova, et al.
Published: (2021-06-01)

Neuroprotective Properties of Inhaled Argon-Oxygen Mixture after Photochemically Induced Ischemic Stroke
by: Ekaterina A. Boeva, et al.
Published: (2023-09-01)

Rationale for Clinical Approaches to the Use of Modern Pharmacological Neuroprotection in Patients after Endovitreal Surgery of Rheumatogenic Retinal Detachment
by: A. V. Egorov, et al.
Published: (2019-08-01)

Correction of endotoxin-induced endothelial dysfunction by recombinant erythropoetin and inhibitors of HMG-Co-A-reductase
by: T. A. Denisyuk, et al.
Published: (2015-12-01)

PATHOPHYSIOLOGICAL BASICS OF ACUTE BRAIN ISCHEMIA MODERN PHARMACOTHERAPY. NOOTROPICS AND ANTIOXIDANTS’ ROLE IN NEUROPROTECTION
by: E. V. Gantsgorn, et al.
Published: (2013-06-01)

NEUROPROTECTIVE EFFECTS OF ERYTHROPOIETIN: OPPORTUNITIES, PROSPECTS AND REALITY (REVIEW)
by: I. Kladova, et al.
Published: (2014-09-01)

Cortical spreading depression produces a neuroprotective effect activating mitochondrial uncoupling protein-5
by: Viggiano E, et al.
Published: (2016-07-01)

Cyanate‐Impaired Angiogenesis: Association With Poor Coronary Collateral Growth in Patients With Stable Angina and Chronic Total Occlusion
by: Jia Teng Sun, et al.
Published: (2016-12-01)

Neuroprotective Eﬀect of Lithium Chloride in Rat Model of Cardiac Arrest
by: I. V. Ostrova, et al.
Published: (2019-07-01)

Neuroprotective effect of intravenous lipid emulsion after bupivacaine-induced cardiac toxicity
by: Mevlüt Doğukan, et al.
Published: (2025-07-01)

Experimental Study of Neuroprotective Properties of Inhaled Argon-Oxygen Mixture in a Photoinduced Ischemic Stroke Model
by: E. A. Boeva, et al.
Published: (2023-06-01)

Relation of cytokine profile and antibody values to post-translational protein modifications in patients with rheumatoid arthritis (preliminary data)
by: D. А. Dibrov, et al.
Published: (2024-04-01)

Current Opportunities and Future Prospects of Neuroprotective Therapy in Glaucoma. Literature Review. Part 1
by: N. I. Kurysheva, et al.
Published: (2025-03-01)